ODX.L Share News (ODX)
ODX Share
ODX Share
ODX Share
ODX Share
ODX
ODX Share
ODX Broker
ODX Directors
ODX Financial
ODX
ODX Short
ODXThu, 02nd Jul 2020 10:32
Omega Diagnostics Group PLC - London-focused medical diagnostics firm - Reports its ELISA antibody test for Covid-19 approved for use in India. Permission to commence sales is conditional on Omega submitted "supporting technical data", though the company is optimistic.
Current stock price: 42.65 pence
Year-to-date change: up roughly threefold from 14.22p on January 2
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
IN BRIEF: Omega Diagnostics Completes AbC-19 Self-Test Usability Study
Read moreIN BRIEF: Omega Diagnostics Reports CE-Mark Of Mologic Covid-19 Test
Read more
(Sharecast News) - Medical diagnostics company Omega announced on Thursday that it has CE-marked Mologic's lateral flow antibody test for Covid-19, for sale under its 'Visitect' brand.
Read moreWHO Prequalification For Omega Diagnostics' HIV Advanced Disease Test
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read more(Sharecast News) - Omega Diagnostics updated the market on the work of the UK Rapid Test Consortium in the development of a Covid-19 'Abc-19' lateral flow antibody test on Thursday, reporting that lead partner Abingdon Health has CE-marked the test for professional use.
Read moreOmega Diagnostics Swings To Loss In Full Year Despite Revenue Growth
Read moreIN BRIEF: Omega Diagnostics Issues 54% Of Shares Under Open Offer
Read more(Sharecast News) - Omega Diagnostics reported the results of its open offer on Wednesday, netting gross proceeds from its recent fundraising of £11m before expenses.
Read more(Sharecast News) - Medical diagnostics company Omega revealed on Thursday that its CE-Marked Mologic ELISA antibody test had been approved for Covid-19 testing in India.
Read moreIN BRIEF: Omega Diagnostics Reports Progress At Virus Consortium
Read more(Sharecast News) - Omega Diagnostics updated the market on an announcement from the UK Rapid Test Consortium (UK-RTC) on Monday, developing a Covid-19 lateral flow antibody test that could be used by people in their homes.
Read moreOmega Diagnostics To Raise Up To GBP11 Million To Develop Products
Read more(Sharecast News) - Omega Diagnostics updated the market on a number of fronts on Tuesday, announcing the signing of a longer-term supply agreement with Mologic, first orders for the Covid-19 'ELISA' test, and the signing of an additional material transfer agreement with Mologic.
Read more
